Wassil Jim
SEC CIK 1813798 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | EVP, COO, Chief Scientific Ofc | 145.4K | — | $11.04M | 83 | 2022-02-24 | 2026-09-08 |
Most active insiders at PCVX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PICKERING GRANT | CEO, Dir | — | $3.63M |
| 2 | GUGGENHIME ANDREW | Pres AND CFO | — | $1.64M |
| 3 | Wassil Jim | EVP, COO, Chief Scientific Ofc | — | $1.43M |
| 4 | Dhaliwal Harpreet S. | Chief Technical Ops Off | — | $1.39M |
| 5 | Cowan Elvia | SVP, Fin | — | $988.6K |
| 6 | Jodar Luis | Chief Medical Off | — | — |
| 7 | Lee Jacks | Dir | — | — |
| 8 | Loxam Teri | Dir | — | — |
| 9 | Furey John | Dir | — | — |
| 10 | Paya Carlos V | Dir | — | — |
Transactions 83
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-09 17:46 | 2026-09-04+ | PCVX | Vaxcyte, Inc. | Wassil Jim | EVP, COO, Chief Scientific Ofc | S - Sale | $60.35 | -2,715 | 145.4K | -2% | -$163.9K |
| 2026-09-09 17:46 | 2026-09-08 | PCVX | Vaxcyte, Inc. | Wassil Jim | EVP, COO, Chief Scientific Ofc | F - Tax | $60.36 | -5,459 | 146.8K | -4% | -$329.5K | |
| DM | 2026-09-02 19:58 | 2026-08-31+ | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $61.18 | -2,705 | 153.6K | -2% | -$165.5K |
| D | 2026-09-02 19:58 | 2026-09-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $5.35 | +2,250 | 158.5K | +1% | +$12.0K |
| DM | 2026-09-02 19:58 | 2026-09-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $61.07 | -3,477 | 155.0K | -2% | -$212.4K |
| DT | 2026-08-05 16:59 | 2026-08-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $5.35 | +2,250 | 159.8K | +1% | +$12.0K |
| DMT | 2026-08-05 16:59 | 2026-08-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $53.86 | -2,250 | 157.5K | -1% | -$121.2K |
| DT | 2026-07-06 18:25 | 2026-07-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $5.35 | +516 | 159.0K | +0.3% | +$2,761 |
| DMT | 2026-07-06 18:25 | 2026-07-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $56.33 | -2,250 | 156.8K | -1% | -$126.7K |
| MT | 2026-06-03 16:59 | 2026-06-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $49.52 | -2,250 | 158.5K | -1% | -$111.4K |
| T | 2026-05-01 17:37 | 2026-05-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $56.83 | -2,250 | 160.7K | -1% | -$127.9K |
| MT | 2026-04-03 16:06 | 2026-04-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $58.43 | -2,250 | 163.0K | -1% | -$131.5K |
| M | 2026-03-11 | 2026-03-10 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $58.88 | -7,395 | 171.8K | -4% | -$435.4K |
| 2026-03-11 | 2026-03-09 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $59.32 | -975 | 174.2K | -0.6% | -$57.8K | |
| DM | 2026-03-02 | 2026-02-27+ | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $61.86 | -3,807 | 175.2K | -2% | -$235.5K |
| DM | 2026-03-02 | 2026-02-26+ | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | A - Grant | $8.48 | +37.1K | 173.9K | +27% | +$315.0K |
| 2025-09-10 | 2025-09-08 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $32.41 | -2,759 | 141.8K | -2% | -$89.4K | |
| M | 2025-09-04 | 2025-09-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $31.56 | -4,286 | 146.3K | -3% | -$135.3K |
| 2025-03-03 | 2024-12-31 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | G - Gift | $0.00 | -74.0K | 131.7K | -36% | $0 | |
| DM | 2025-03-03 | 2025-02-27+ | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | A - Grant | $15.07 | +27.4K | 159.1K | +21% | +$412.5K |
| DM | 2025-03-03 | 2025-02-28+ | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $72.63 | -7,154 | 151.9K | -4% | -$519.6K |
| DM | 2025-03-03 | 2025-03-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $4.38 | +8,000 | 162.9K | +5% | +$35.1K |
| DM | 2025-03-03 | 2025-03-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $73.27 | -8,000 | 154.9K | -5% | -$586.2K |
| D | 2025-02-04 | 2025-02-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| DM | 2025-02-04 | 2025-02-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $86.23 | -8,000 | 208.4K | -4% | -$689.8K |
| DM | 2025-01-03 | 2025-01-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $83.66 | -8,000 | 205.7K | -4% | -$669.3K |
| D | 2025-01-03 | 2025-01-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| DM | 2024-12-03 | 2024-12-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $92.49 | -8,000 | 206.8K | -4% | -$739.9K |
| D | 2024-12-03 | 2024-12-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| DM | 2024-11-04 | 2024-11-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $106.80 | -8,000 | 206.6K | -4% | -$854.4K |
| D | 2024-11-04 | 2024-11-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| DM | 2024-10-29 | 2024-10-28 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $16.04 | +5,049 | 205.7K | +3% | +$81.0K |
| DM | 2024-10-03 | 2024-10-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $114.24 | -8,000 | 206.3K | -4% | -$914.0K |
| D | 2024-10-03 | 2024-10-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 208.6K | +4% | +$19.4K |
| DM | 2024-09-18 | 2024-09-16 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $115.97 | -10.0K | 200.6K | -5% | -$1.16M |
| D | 2024-09-18 | 2024-09-16 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +10.0K | 212.0K | +5% | +$24.2K |
| DM | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $111.93 | -10.0K | 209.1K | -5% | -$1.12M |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $110.15 | -5,545 | 202.0K | -3% | -$610.8K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +10.0K | 217.5K | +5% | +$24.2K |
| M | 2024-08-05 | 2024-08-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $78.84 | -3,000 | 207.5K | -1% | -$236.5K |
| M | 2024-07-02 | 2024-07-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $76.34 | -3,000 | 212.3K | -1% | -$229.0K |
| M | 2024-06-05 | 2024-06-03 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $71.99 | -3,000 | 213.5K | -1% | -$216.0K |
| M | 2024-05-03 | 2024-05-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $61.65 | -3,000 | 215.5K | -1% | -$184.9K |
| D | 2024-04-19 | 2024-04-17 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $5.35 | +3,551 | 221.8K | +2% | +$19.0K |
| M | 2024-04-03 | 2024-04-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $66.69 | -3,000 | 218.3K | -1% | -$200.1K |
| 2024-03-19 | 2024-03-15 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | A - Grant | $0.00 | +4,099 | 222.8K | +2% | $0 | |
| 2024-03-19 | 2024-03-15 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $69.70 | -1,484 | 221.3K | -0.7% | -$103.4K | |
| DM | 2024-03-04 | 2024-03-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale | $73.71 | -3,000 | 221.6K | -1% | -$221.1K |
| D | 2024-03-04 | 2024-03-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $71.55 | -2,178 | 218.7K | -1.0% | -$155.8K |
| D | 2024-03-04 | 2024-02-29 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | A - Grant | $0.00 | +20.0K | 223.9K | +10% | $0 |
| D | 2024-02-20 | 2024-02-15 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +27.9K | 203.9K | +16% | +$67.6K |
| DM | 2024-02-05 | 2024-02-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $73.88 | -3,000 | 177.4K | -2% | -$221.6K |
| D | 2024-02-05 | 2024-02-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 178.9K | +2% | +$7,260 |
| DM | 2024-01-04 | 2024-01-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $63.91 | -3,000 | 177.6K | -2% | -$191.7K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 178.9K | +2% | +$7,260 |
| DM | 2023-12-05 | 2023-12-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $52.14 | -3,000 | 177.9K | -2% | -$156.4K |
| D | 2023-12-05 | 2023-12-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 178.9K | +2% | +$7,260 |
| DM | 2023-11-03 | 2023-11-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $47.26 | -3,000 | 176.1K | -2% | -$141.8K |
| D | 2023-11-03 | 2023-11-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 178.9K | +2% | +$7,260 |
| D | 2023-10-16 | 2023-10-12 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +5,000 | 175.9K | +3% | +$12.1K |
| DM | 2023-10-04 | 2023-10-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $50.43 | -3,000 | 170.9K | -2% | -$151.3K |
| D | 2023-10-04 | 2023-10-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 173.9K | +2% | +$7,260 |
| D | 2023-09-26 | 2023-09-22 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 170.9K | +2% | +$7,260 |
| D | 2023-09-06 | 2023-09-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 173.1K | +2% | +$7,260 |
| D | 2023-09-06 | 2023-09-05 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $51.00 | -2,131 | 167.9K | -1% | -$108.7K |
| DM | 2023-09-06 | 2023-09-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $52.82 | -3,000 | 170.1K | -2% | -$158.4K |
| D | 2023-03-03 | 2023-03-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | A - Grant | $0.00 | +22.5K | 170.2K | +15% | $0 |
| D | 2023-03-03 | 2023-03-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $41.49 | -1,189 | 169.0K | -0.7% | -$49.3K |
| D | 2022-12-28 | 2022-12-23 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +105.4K | 147.7K | +249% | +$255.0K |
| D | 2022-10-19 | 2022-10-17 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 45.1K | +7% | +$6,776 |
| DM | 2022-10-19 | 2022-10-17 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $25.72 | -2,800 | 42.3K | -6% | -$72.0K |
| DM | 2022-09-21 | 2022-09-19 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $26.11 | -2,800 | 42.3K | -6% | -$73.1K |
| D | 2022-09-21 | 2022-09-19 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 45.1K | +7% | +$6,776 |
| 2022-09-07 | 2022-09-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | F - Tax | $26.38 | -2,162 | 42.3K | -5% | -$57.0K | |
| D | 2022-08-19 | 2022-08-17 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $25.15 | -2,800 | 44.5K | -6% | -$70.4K |
| D | 2022-08-19 | 2022-08-17 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 47.3K | +6% | +$6,776 |
| D | 2022-07-06 | 2022-07-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 47.3K | +6% | +$6,776 |
| D | 2022-07-06 | 2022-07-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $22.00 | -2,800 | 44.5K | -6% | -$61.6K |
| D | 2022-04-20 | 2022-04-18 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 45.7K | +7% | +$6,776 |
| D | 2022-04-20 | 2022-04-18 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $23.98 | -2,800 | 42.9K | -6% | -$67.1K |
| D | 2022-03-04 | 2022-03-02 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | A - Grant | $0.00 | +25.0K | 42.9K | +139% | $0 |
| D | 2022-02-28 | 2022-02-24 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | S - Sale+OE | $22.00 | -10.0K | 17.9K | -36% | -$220.0K |
| D | 2022-02-28 | 2022-02-24 | PCVX | Vaxcyte, Inc. | Wassil Jim | COO | M - OptEx | $2.42 | +10.0K | 27.9K | +56% | +$24.2K |
Purchase Sale Sale after option exercise All abbreviations